---
name: G3.1 Absent Transformation Zone on Screening Cytology in Patient Age 21-30 (obs)

externalData:
- resources

data:
- 
  resourceType: Patient
  name: Joanne Smith
  gender: female
  birthDate: 1996-01-01
  extension:
  -
    url: http://hl7.org/fhir/us/core/StructureDefinition/us-core-birthsex
    valueCode: F
- 
  resourceType: DiagnosticReport
  code: LOINC#10524-7 Microscopic observation [Identifier] in Cervix by Cyto stain
  status: final
  result:
  - reference: Observation/1
  - reference: Observation/2
  effectiveDateTime: 2021-05-01
-
  resourceType: Observation
  id: 1
  code: LOINC#10524-7 Microscopic observation [Identifier] in Cervix by Cyto stain
  status: final
  valueCodeableConcept: SNOMEDCT#412716005 Cervical smear transformation zone cells absent (situation)
  effectiveDateTime: 2021-05-01
-
  resourceType: Observation
  id: 2
  code: LOINC#10524-7 Microscopic observation [Identifier] in Cervix by Cyto stain
  status: final
  valueCodeableConcept: SNOMEDCT#373887005 Negative for intraepithelial lesion or malignancy (finding)
  effectiveDateTime: 2021-05-01

results:
  Recommendation: 
    short: 'See Details'
    date: '2021-06-02'
    group: 'Rare Cytology (G.3.1)'
    details:
    - 'Routine screening is recommended (BIII). When cervical cytology alone is performed for screening, HPV testing as a triage test after negative cytology and absent endocervical cells/transformation zone component in this age group is unacceptable (DIII).'
  WhichRarityMadeTheRecommendation: 1